newsfilter
← Latest News
GlobeNewswire·

ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 1, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN)) ("ObsEva" or the "Company"), a biopharmaceutical company developing